Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

ERCP in infants, children, and adolescents-Different roles of the methods in different age groups

R. Keil, J. Drábek, J. Lochmannová, J. Šťovíček, P. Koptová, M. Wasserbauer, B. Frýbová, J. Šnajdauf, J. Matouš, R. Kotalová, M. Rygl, Š. Hlava,

. 2019 ; 14 (1) : e0210805. [pub] 20190117

Language English Country United States

Document type Journal Article, Observational Study, Research Support, Non-U.S. Gov't

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is seldom used in children, and published series have limited numbers of pediatric patients. The aim of this retrospective observational study was to assess the efficacy and safety of pediatric ERCP in a large group of children. METHODS: Data were evaluated from 626 children with biliopancreatic disorders admitted to University Hospital Motol, Prague, between January 1999 and January 2018. Clinical data were obtained by retrospective evaluation of our database of pediatric ERCP procedures and from clinical records. RESULTS: We performed 856 ERCPs on 626 pediatric patients; of these procedures, 59% were therapeutic and 41% were diagnostic. We achieved 96% technical success. Indications for ERCP and pathological findings differed in different age groups. The main role of ERCP was in excluding biliary atresia in those aged less than one year. In children aged 1 to 6 years, the most frequent diagnoses were choledochal cyst followed by choledocholithiasis. In children aged 7 to 12 years and 13 to 19 years, the most frequent diagnoses were choledocholithiasis followed by pancreatic pathology. The overall complication rate found in this study was similar to rates observed in adult populations. CONCLUSIONS: Our study shows the efficacy and safety of diagnostic and therapeutic ERCP in a large series of infants and children with technical success and complication rates comparable to those in adults. Our data show that ERCP had different roles in different age groups of children.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045044
003      
CZ-PrNML
005      
20231121144533.0
007      
ta
008      
200109s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0210805 $2 doi
035    __
$a (PubMed)30653580
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Keil, Radan $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
245    10
$a ERCP in infants, children, and adolescents-Different roles of the methods in different age groups / $c R. Keil, J. Drábek, J. Lochmannová, J. Šťovíček, P. Koptová, M. Wasserbauer, B. Frýbová, J. Šnajdauf, J. Matouš, R. Kotalová, M. Rygl, Š. Hlava,
520    9_
$a BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is seldom used in children, and published series have limited numbers of pediatric patients. The aim of this retrospective observational study was to assess the efficacy and safety of pediatric ERCP in a large group of children. METHODS: Data were evaluated from 626 children with biliopancreatic disorders admitted to University Hospital Motol, Prague, between January 1999 and January 2018. Clinical data were obtained by retrospective evaluation of our database of pediatric ERCP procedures and from clinical records. RESULTS: We performed 856 ERCPs on 626 pediatric patients; of these procedures, 59% were therapeutic and 41% were diagnostic. We achieved 96% technical success. Indications for ERCP and pathological findings differed in different age groups. The main role of ERCP was in excluding biliary atresia in those aged less than one year. In children aged 1 to 6 years, the most frequent diagnoses were choledochal cyst followed by choledocholithiasis. In children aged 7 to 12 years and 13 to 19 years, the most frequent diagnoses were choledocholithiasis followed by pancreatic pathology. The overall complication rate found in this study was similar to rates observed in adult populations. CONCLUSIONS: Our study shows the efficacy and safety of diagnostic and therapeutic ERCP in a large series of infants and children with technical success and complication rates comparable to those in adults. Our data show that ERCP had different roles in different age groups of children.
650    _2
$a mladiství $7 D000293
650    _2
$a věkové faktory $7 D000367
650    _2
$a nemoci žlučového ústrojí $x diagnóza $x chirurgie $7 D001660
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a cholangiopankreatografie endoskopická retrográdní $x škodlivé účinky $x přístrojové vybavení $x metody $7 D002760
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nemoci slinivky břišní $x diagnóza $x chirurgie $7 D010182
650    _2
$a pooperační komplikace $x radioterapie $7 D011183
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a bezpečnost $7 D012449
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Drábek, Jiří $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Lochmannová, Jindra, $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic. $d 1968- $7 xx0063944
700    1_
$a Šťovíček, Jan $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Koptová, Petra $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Wasserbauer, Martin, $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic. $d 1987- $7 xx0302700
700    1_
$a Frýbová, Barbora $u Department of Pediatric Surgery, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Šnajdauf, Jiří $u Department of Pediatric Surgery, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Matouš, Jan $u 2nd Department of Internal Medicine Charles University, 3rd Faculty of Medicine, FNKV, Prague, Czech Republic.
700    1_
$a Kotalová, Radana $u Department of Pediatry, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Rygl, Michal $u Department of Pediatric Surgery, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
700    1_
$a Hlava, Štěpán $u Department of Internal Medicine, Charles University, 2nd Faculty of Medicine, University Hospital Motol, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 14, č. 1 (2019), s. e0210805
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30653580 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20231121144530 $b ABA008
999    __
$a ok $b bmc $g 1483313 $s 1083717
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 14 $c 1 $d e0210805 $e 20190117 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...